Clinical Trial Update: Cytomegalovirus Hyperimmune Globulin (CMV-Ig) Replacement in Hypogammaglobulinemic Lung Transplant Recipients [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 trial evaluating Cytomegalovirus hyperimmune globulin (CMV-Ig) replacement in hypogammaglobulinemic lung transplant recipients; the study has co…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection
• Hypogammaglobulinemia

Drugs mentioned

• CytoGam (Cytomegalovirus immune globulin)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Hypogammaglobulinemia | Phase 2, Phase 3 | Status: COMPLETED